↓ Skip to main content

Self-reported indications for antidepressant use in a population-based cohort of middle-aged and elderly

Overview of attention for article published in International Journal of Clinical Pharmacy, September 2016
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (66th percentile)
  • Good Attention Score compared to outputs of the same age and source (66th percentile)

Mentioned by

policy
1 policy source
twitter
2 X users

Citations

dimensions_citation
22 Dimensions

Readers on

mendeley
60 Mendeley
Title
Self-reported indications for antidepressant use in a population-based cohort of middle-aged and elderly
Published in
International Journal of Clinical Pharmacy, September 2016
DOI 10.1007/s11096-016-0371-9
Pubmed ID
Authors

Nikkie Aarts, Raymond Noordam, Albert Hofman, Henning Tiemeier, Bruno H. Stricker, Loes E. Visser

Abstract

Background Population-based studies investigating indications for antidepressant prescribing mostly rely on diagnoses from general practitioners. However, diagnostic codes might be incomplete and drugs may be prescribed 'off-label' for indications not investigated in clinical trials. Objective We aimed to study indications for antidepressant use based on self-report. Also, we studied the presence of depressive symptoms associated with the self-reported indications. Setting Our study population of antidepressant users was selected based on interview data between 1997 and 2013 from the prospective population-based Rotterdam Study cohort (age >45 years). Method Antidepressant use, self-reported indication for use, and presence of depressive symptoms (Center for Epidemiological Studies Depression Scale) were based on interview. Self-reported indications were categorized by the researchers into officially approved, clinically-accepted and commonly mentioned off-label indications. Main outcome measures A score of 16 and higher on the Center for Epidemiological Studies Depression Scale was considered as indicator for clinically-relevant depressive symptoms. Results The majority of 914 antidepressant users reported 'depression' (52.4 %) as indication for treatment. Furthermore, anxiety, stress and sleep disorders were reported in selective serotonin reuptake inhibitor and other antidepressant users (ranging from 5.9 to 13.3 %). The indication 'pain' was commonly mentioned by tricyclic antidepressant users (19.0 %). Indications were statistically significantly associated with higher depressive symptom scores when compared to non-users (n = 10,979). Conclusions Depression was the main indication for antidepressant treatment. However, our findings suggest that antidepressants are also used for off-label indications, subthreshold disorders and complex situations, which were all associated with clinically-relevant depressive symptoms in the middle-aged and elderly population.

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 60 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 60 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 10 17%
Student > Doctoral Student 8 13%
Student > Bachelor 8 13%
Researcher 3 5%
Other 3 5%
Other 12 20%
Unknown 16 27%
Readers by discipline Count As %
Medicine and Dentistry 19 32%
Pharmacology, Toxicology and Pharmaceutical Science 8 13%
Nursing and Health Professions 4 7%
Chemistry 2 3%
Social Sciences 2 3%
Other 5 8%
Unknown 20 33%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 11 September 2021.
All research outputs
#6,979,897
of 22,886,568 outputs
Outputs from International Journal of Clinical Pharmacy
#391
of 1,092 outputs
Outputs of similar age
#108,834
of 337,400 outputs
Outputs of similar age from International Journal of Clinical Pharmacy
#8
of 24 outputs
Altmetric has tracked 22,886,568 research outputs across all sources so far. This one has received more attention than most of these and is in the 68th percentile.
So far Altmetric has tracked 1,092 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.4. This one has gotten more attention than average, scoring higher than 61% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 337,400 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 66% of its contemporaries.
We're also able to compare this research output to 24 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 66% of its contemporaries.